To evaluate the long-term effects of drospirenone (DRSP)/ethinylestradiol (EE) alone, metformin alone, and DRSP/EE-metformin on CD4(+)CD28(null) T lymphocytes frequency, a cardiovascular risk marker, in patients with hyperinsulinemic polycystic ovary syndrome (PCOS).
Moro, F., Morciano, A., Tropea, A., Sagnella, F., Liuzzo, G., Scarinci, E., Ciardulli, A., Martinez, D., Familiari, A., Liuzzo, G., Tritarelli, A., Cosentino, N., Niccoli, G., Crea, F., Lanzone, A., Apa, R., Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial, <<REPRODUCTIVE SCIENCES>>, 2013; 20 (12): 1508-1517. [doi:10.1177/1933719113488444] [http://hdl.handle.net/10807/53440]
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial
Moro, Francesca;Morciano, Andrea;Tropea, Anna;Sagnella, Francesca;Liuzzo, Giovanna;Scarinci, Elisa;Ciardulli, Andrea;Martinez, Daniela;Familiari, Alessandra;Niccoli, Giampaolo;Crea, Filippo;Lanzone, Antonio;Apa, Rosanna
2013
Abstract
To evaluate the long-term effects of drospirenone (DRSP)/ethinylestradiol (EE) alone, metformin alone, and DRSP/EE-metformin on CD4(+)CD28(null) T lymphocytes frequency, a cardiovascular risk marker, in patients with hyperinsulinemic polycystic ovary syndrome (PCOS).
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
